Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial
article
OA: bronze
CC0
⤵ 205 in-corpus citations
AI-generated summary
This randomized, double-blind trial investigated the efficacy of a low-dose oral contraceptive pill in treating dysmenorrhea in women with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (16)
- Add-back therapy in the treatment of endometriosis-associated pain via openalex
- Advances in the management of endometriosis: an update for clinicians via openalex
- A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Does contraception modify the risk of endometriosis? via openalex
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
- Endometriosis via openalex
- Etiology and epidemiology of endometriosis via openalex
- Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial via openalex
- Treatment of Endometriosis via openalex
- W2062278361 via openalex
- W1968456293 via openalex
- W2094252128 via openalex
- W2322133447 via openalex
- W1661158834 via openalex
- W2166744769 via openalex
Cited by (50)
- Over‐the‐Counter Provision of Oral Contraceptive Pills for Patients With Dysmenorrhea, Suspected or Confirmed Endometriosis or Chronic Pelvic Pain: A Systematic Review and Evidence Gaps 2026
- The Microbiota–Endometriosis Axis: An Immune–Endocrine Integration Model and Emerging Therapeutic Targets 2026
- Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
- Pharmacologic Interventions for Endometriosis-Related Pain 2025
- The role of pharmacotherapy in the treatment of endometriosis: an update 2025
- Patient preference for treatment of an endometrioma, a qualitative study 2025
- Comparative Study of 0.5 mg Dienogest Tablets (1 mg/Day) and Continuous Low-Dose Estrogen/Progestin for Dysmenorrhea: A Retrospective Analysis—Influence of Bleeding-Related Factors Such as Endometrial Polyps, Uterine Fibroids, and Adenomyosis 2025
- Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age - a systematic review 2024
- The long road of drug development for endometriosis - Pains, gains, and hopes 2024
- Safety and efficacy of pharmacotherapies for pelvic inflammatory disease and endometriosis 2024
- Experience of using drospirenone/ethinyl estradiol combination in women of reproductive age 2024
- MRI classification of uterosacral ligament involvement in endometriosis: the Hôtel-Dieu classification 2024
- Efficacy of 0.5 mg Dienogest Tablets in Treating Premenstrual Syndrome-like Symptoms: A Comparative Study with a Low-Dose Estrogen–Progestin Combination 2024
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Pain Management for Women with Endometriosis 2024
- Outpatient diagnosis and drug therapy of endometriosis: A review 2024
- Multifaceted analysis in the surgery of the endometriotic cyst and the significance of the resection of the median pelvic endometriosis 2024
- Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023 2024
- A multicentre phase III study comparing efficacy & safety of novel extended-release vs. conventional formulation of Dydrogesterone in Indian patients with endometriosis 2024
- Comparison of dienogest or combinations with ethinylestradiol/estradiol valerate on the pain score of women with endometriosis: A prospective cohort study 2024
- Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial (Preprint) 2024
- Efficacy and Safety of Sanjie Analgesic Capsule in Patients with Endometriosis-Associated Pain: A Multicenter, 3:1 Randomized, Double-Blind, Placebo-Controlled Trial 2024
- Chronic Abdominal Pain Due to Obstetric and Gynecological Factors 2024
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- Endometriosis 2024
- Medical Management of Ovarian Endometriomas 2023
- Progestins and combined oral contraceptives in the hormonal treatment of endometriosis – a review 2023
- Evaluation of the Characteristics of Ovarian Endometriomas in Patients with Endometriosis: Efficacy of a Low-Dose Estrogen/Progestogen Combination 2023
- Clinical and sonographic impact of oral contraception in patients with deep endometriosis and adenomyosis at 2 years of follow-up 2023
- Expectant, Medical, and Surgical Management of Ovarian Endometriomas 2023
- Effect of hormonal treatment on evolution of endometriomas: An observational study 2023
- Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics 2023
- Hormonal Therapy in Endometriosis and Adenomyosis: Oral Contraceptives 2022
- Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis 2022
- Clinical practice guidelines for endometriosis in Japan (The 3rd edition) 2022
- Estro-Progestins and Pain Relief in Endometriosis 2022
- Medical treatments of endometriosis: a review 2022
- Structural Gynecological Disease 2022
- Thai Interest Group for Endometriosis (TIGE) consensus statement on endometriosis-associated pain 2022
- Long-term efficacy and safety of levonorgestrel-releasing intrauterine system as a maintenance treatment for endometriosis 2022
- The issues of endometriosis hormonal treatment in reproductive age women 2022
- Management of Ovarian Endometrioma in Asymptomatic Reproductive Age Women 2021
- Gestagenes in the treatment of endometriosis: efficiency, safety, bioequivalence, transferability 2021
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- Chronic Pelvic Pain 2021
- Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial 2021
- Non-contraceptive Benefits of Hormonal Methods 2021
- An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open‐label multicenter clinical study 2021
- Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study 2021
- Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review 2021
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:42.556217+00:00
License: CC0
· commercial use OK